Literature DB >> 34142270

Knockdown of TRIM15 inhibits the activation of hepatic stellate cells.

Junpei Zhang1, Yin Chen1, Yi Tian2, Shiyao Chen3, Hailing Liu4.   

Abstract

Liver fibrosis is a global public health problem, and the activation of hepatic stellate cells (HSCs) is the main driving force for liver fibrosis. However, the activation mechanism of HSCs is still not fully understood. In this study, we screened out 854 differentially expressed genes [Log2 fold change absolute: log2 FC(abs) ≥ 1] in activated LX-2 cells. Subsequently, we performed functional analyses of these differentially expressed genes. Gene Ontology enrichment analysis showed that the target genes were mainly enriched in processes such as positive regulation of cell migration involved in sprouting angiogenesis, negative regulation of keratinocyte proliferation, and nuclear inclusion bodies. Kyoto Encyclopedia of Gene and Genome signaling pathway enrichment analysis revealed that dysregulated genes were involved in signaling pathways such as pantothenate and coenzyme A biosynthesis and riboflavin metabolism. The microarray results were validated by reverse transcription-quantitative polymerase chain reaction, which indicated that the microarray results were reliable and that the tripartite motif containing 15 (TRIM15) had the highest absolute value of Log2FC. Additionally, the effect of TRIM15 on the proliferation, migration, and activation of LX-2 cells was assessed using overexpression plasmids and siRNA transfections. TRIM15 promoted the proliferation and migration of LX-2 cells and positively regulated the expression of α-smooth muscle actin and type I collagen. Collectively, the data revealed the gene expression profiles of quiescent and activated LX-2 cells and the involvement of TRIM15 in the activation of LX-2 cells. Hereby, TRIM15 could be a novel target of the HSC activation mechanism.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Hepatic stellate cell; Microarray analysis; TRIM15

Mesh:

Substances:

Year:  2021        PMID: 34142270     DOI: 10.1007/s10735-021-09997-7

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  30 in total

1.  Trolline Ameliorates Liver Fibrosis by Inhibiting the NF-κB Pathway, Promoting HSC Apoptosis and Suppressing Autophagy.

Authors:  Facheng Bai; Quanfang Huang; Jinlan Nie; Shengjuan Lu; Chunyuan Lu; Xunshuai Zhu; Yuxin Wang; Lang Zhuo; Zhongpeng Lu; Xing Lin
Journal:  Cell Physiol Biochem       Date:  2017-11-15

Review 2.  Clinical evidence for the regression of liver fibrosis.

Authors:  Elizabeth L Ellis; Derek A Mann
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

Review 3.  Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal.

Authors:  Ramón Bataller; Kari E North; David A Brenner
Journal:  Hepatology       Date:  2003-03       Impact factor: 17.425

Review 4.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.

Authors:  Weiwei Chen; Zili Zhang; Zhen Yao; Ling Wang; Feng Zhang; Jiangjuan Shao; Anping Chen; Shizhong Zheng
Journal:  Int Immunopharmacol       Date:  2018-02-03       Impact factor: 4.932

Review 6.  TGF-β in progression of liver disease.

Authors:  Steven Dooley; Peter ten Dijke
Journal:  Cell Tissue Res       Date:  2011-10-19       Impact factor: 5.249

7.  Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.

Authors:  Guifang Du; Jing Wang; Ting Zhang; Qiang Ding; Xiaodong Jia; Xueke Zhao; Jinke Dong; Xinrui Yang; Shanshan Lu; Cuihong Zhang; Ze Liu; Zhen Zeng; Rifaat Safadi; Ruizhao Qi; Xin Zhao; Zhixian Hong; Yinying Lu
Journal:  Cell Death Dis       Date:  2020-02-12       Impact factor: 8.469

Review 8.  TRIM proteins in blood cancers.

Authors:  Lisa J Crawford; Cliona K Johnston; Alexandra E Irvine
Journal:  J Cell Commun Signal       Date:  2017-11-06       Impact factor: 5.782

9.  PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β-catenin signalling pathway.

Authors:  Yu Chen; Xin Chen; Ya-Ru Ji; Sai Zhu; Fang-Tian Bu; Xiao-Sa Du; Xiao-Ming Meng; Cheng Huang; Jun Li
Journal:  J Cell Mol Med       Date:  2020-05-28       Impact factor: 5.310

View more
  1 in total

Review 1.  Best Practices and Progress in Precision-Cut Liver Slice Cultures.

Authors:  Liza Dewyse; Hendrik Reynaert; Leo A van Grunsven
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.